7N1X
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
Summary for 7N1X
Entry DOI | 10.2210/pdb7n1x/pdb |
EMDB information | 24126 |
Descriptor | Spike glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, ... (5 entities in total) |
Functional Keywords | viral protein |
Biological source | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV, SARS-CoV-2) |
Total number of polymer chains | 3 |
Total formula weight | 453018.22 |
Authors | Zhang, J.,Cai, Y.F.,Xiao, T.S.,Rawson, S.,Peng, H.Q.,Sterling, S.M.,Walsh Jr, R.M.,Volloch, S.R.,Chen, B. (deposition date: 2021-05-28, release date: 2021-07-07, Last modification date: 2021-08-18) |
Primary citation | Cai, Y.,Zhang, J.,Xiao, T.,Lavine, C.L.,Rawson, S.,Peng, H.,Zhu, H.,Anand, K.,Tong, P.,Gautam, A.,Lu, S.,Sterling, S.M.,Walsh Jr., R.M.,Rits-Volloch, S.,Lu, J.,Wesemann, D.R.,Yang, W.,Seaman, M.S.,Chen, B. Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants. Science, 373:642-648, 2021 Cited by PubMed: 34168070DOI: 10.1126/science.abi9745 PDB entries with the same primary citation |
Experimental method | ELECTRON MICROSCOPY (4 Å) |
Structure validation
Download full validation report